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Abstract 
The opioid crisis has taken America by storm and is causing more deaths each year than ever originally 
anticipated. Our current approach to addressing the opioid crisis involves two separate approaches, one 
from the medical/rehabilitation side of the problem, and one from the criminal justice side. This article 
serves as a revisiting of the discussion of the intricate balance that must be reached between 
rehabilitation and incarceration in order to adequately address the problem. 
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Introduction 
 
The opioid crisis has taken the country by surprise over the past decade or so. Since the issue has become 
relevant because of its danger to the public, more and more information has become available about not 
only the dangers for addicts, but also for affected families and friends. The opioid crisis has caused at least 
600,000 deaths to date, and is expected to increase to almost 800,000 by 2020.1 Opioid addiction afflicts  
about 10 percent of the approximately 20 million United States residents who struggle with substance abuse 
disorders.2 The 2017 UN report on narcotic use shows that the United States is a significant outlier 
compared to other countries. The US leads the world in narcotic use by 50% over the second place country, 
Germany.3 The Organisation for Economic Cooperation and Development (OECD) reports that the 
availability of opioid medications in the US is much higher than in other countries. The US is ahead of 
Germany by over 20,000 defined daily doses for statistical purposes (S-DDD) per million inhabitants, 
almost double the roughly 23,000 S-DDD measured in Germany in 2011.4 
 
1 Max Blau,  “Opioids could kill nearly 500,000 Americans in the next decade,” 
https://www.statnews.com/2017/06/27/opioid-deaths-forecast/. June 27, 2017. Accessed August 16, 2017. 
2 American Society of Addiction Medicine, “Opioid Addiction 2016 Facts and Figures,” American Society of 
Addiction Medicine (2016). 
3 International Narcotics Control Board, “Narcotic Drugs - Technical Report,” Accessed 4/13/2019. 
https://www.incb.org/incb/en/narcotic-drugs/Technical_Reports/narcotic_drugs_reports.html 
4 Organisation for Economic Cooperation and Development, “Opioids use,” Accessed 10/10/2019. 
https://www.oecd-ilibrary.org/sites/652ef96a-en/index.html?itemId=/content/component/652ef96a-
en&mimeType=text/html 
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The Current State of Law and Practice in the US 
 
For drug abuse in general 
 
There are many laws that apply to those who struggle with drug abuse and substance use disorders. Title 
21 United States Code (USC) Controlled Substances Act designates that it is unlawful for any non-medical 
professional or dispenser to manufacture, distribute, or produce a controlled substance in any situation. The 
Drug Enforcement Administration (DEA) has a division known as the Office of Diversion Control which 
is responsible for enforcing this act.5 
 
There has been a large increase in the number of those under some form of criminal justice supervision in 
the past twenty years.6 Along with this, it seems that this increase in a population of those under supervision 
is indicative of a larger shift toward more strict laws and penalties associated with drug-related offenses.7  
 
For overdose and opioid addiction 
In August 2017, President Trump announced that he wanted to declare a state of national emergency as a 
response to the impending danger of the opioid crisis.8 It is clear that opioid addiction is something that is 
being addressed on a national and international scale, but currently, our mainline method for addressing the 
opioid crisis is incarceration. Incarceration for opioid addiction is not necessarily the only option that the 
 
5 Title 21 United States Code (USC) Controlled Substances Act, Drug Enforcement Administration Diversion Control 
Division, Accessed 04/11/2019. https://www.deadiversion.usdoj.gov/21cfr/21usc/index.html 
6 Lauren Glaze, Thomas Bonczar, “Probation and Parole in the United States, 2005,” Washington, DC: Office of 
Justice Programs, Bureau of Justice Statistics; 2006. Dept of Justice. 
7 Eric Jensen, Jurg Gerber, Clayton Mosher, “Social consequences of the War on Drugs: the legacy of failed policy,” 
Criminal Justice Policy Review. 15, no. 1 (2004): 100-121. 
8 Donald Trump, “President’s Commission on Combating Drug Addiction and the Opioid Crisis,” Interim Report. 
Washington, DC (2017). Accessed 04/15/2019, https://www.whitehouse.gov/ondcp/presidents-commission. 
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United States’ criminal justice system uses in order to combat the issue. Treatments such as therapeutic 
substitutes for incarceration, treatment with prison- and jail-based oversight, and reentry programs to help 
with transition from incarceration into society once again have all been utilized.9 Cognitive therapies that 
help with coping and decision-making skills are some of the most effective therapies available, so 
behavioral treatments have been utilized in the past.  
 
The current state of the criminal justice system in regard to addicts and substance abusers does not allow 
much opportunity for treatment. Of state inmates, who make up the majority of incarcerated individuals, 
15% of them received treatment for drug abuse, while more than 50% of them met the criteria for treatment. 
While many of the treatment options for addiction that can be utilized for offenders and are effective, a 
majority of prisons and jails do not, and many addicts continue to suffer as a result.10 While the researchers 
don’t advocate for any strong changes in the justice system itself, they stress that unless the criminal justice 
system changes the way it reacts to addiction and opioid abuse, the problem will only continue to grow and 
incarceration rates will increase year after year.11 
 
Advocacy for Change in America Based on International Standards 
 
How drug addiction is handled in other countries 
 
 
9 Kevin Knight, David Farabee, “Treating Addicted Offenders: A Continuum of Effective Practices,” Kingston, NJ: 
Civic Research Institute (2004) 
10 Redonna Chandler, Bennett Fletcher, and Nora Volkow, “Treating Drug Abuse and Addiction in the Criminal 
Justice System: Improving Public Health and Safety,” JAMA 301, no. 2 (2009): 183-190 
11 Ibid.  
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In 2001, Portugal became the first European country to eliminate all criminal penalties for personal drug 
possession.. Researchers provided therapy to drug users rather than prison or jail sentences.12 Researchers 
found that not only had use decreased in adolescents, but HIV infections and deaths related to heroin had 
also decreased by almost half. The number of people who were actively seeking treatment had doubled, 
showing their central goals of the decriminalization had been achieved.13 These results can be attributed to 
Portugal’s renewed focus on harm reduction strategies in addition to widespread education about opioid 
use and its danger. 
 
In the late 1990s, Switzerland decided to stop trying to fight the use of drugs in their country, but rather to 
focus on the importance of caring for those who struggle with substance abuse. The country implemented 
legalized drug consumption rooms and heroin-assisted treatment facilities to attempt to make the use of 
drugs in the country safe. The number of opioid-related deaths in Switzerland has decreased by over 60 
percent, and HIV infections also significantly dropped.14 The Swiss government has a strong focus on 
allowing as many people into treatment in order to reduce harm as possible. 
 
How those forms of legislation would look in America 
 
What would it look like to implement similar rules and legalizations in the US? It’s clear that the United 
States is one of the worst cases of an opioid crisis in the world, and that the current methods being utilized 
are not functioning effectively enough to make a substantial difference. However, wouldn’t completely 
abolishing certain punishment levels from American justice system practice solve the problem? It’s true 
that decriminalizing illicit drugs in some European countries has helped to curb addiction and assist in 
 
12 Caitlin Hughes & Alex Stevens, “The effects of the decriminalization of drug use in Portugal. Discussion paper.” 
The Beckley Foundation, Oxford (2007) 
13 Glenn Greenwald, “Drug decriminalization in portugal: lessons for creating fair and successful drug policies,” 
CATO Institute (2009).  
14 Addiction | Suisse “Addiction Suisse “Facts and Figures” Accessed 04/13/2019. https://faits-
chiffres.addictionsuisse.ch/fr/opioides/consequences/injections-mortalite.html 
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decreasing overdose levels, but that does not necessarily translate into our American culture the exact same 
way. In order to discover the efficacy of such means, etc., it would be crucial for studies to be done in small 
populations before widespread implementation could occur. Either way, it seems clear from the literature 
that decriminalization has promise in this field, as long as it is accompanied by shifts in treatment and care 
that allow individuals access to methods and interventions that will allow them to recover.  
Legislation similar to this kind of decriminalization has been occurring for years relating to marijuana use. 
The use of marijuana has become legal in many states for various uses, and the long-term effects of this 
legislation has yet to be researched in full. Being able to see how these changes affect the public could play 
a huge role in helping to decide how legislation should move forward in the world of legalization of opioid 
medications. Of course, marijuana and opioid use are two very separate issues, and it’s impossible to 
compare them directly, even if decriminalization of marijuana is successful in a cost-risk scenaria. The 
concepts could be compared and then pros and cons from marijuanas legalization could potentially be 
applied to any future legislation related to opioid use.  
Future research needs to be done in order to establish which forms of care and treatment are the most 
efficient along with research proving weather or not localized decriminalization is effective for curbing 
overdose and addiction cases. In addition, further research would need to be done in different geographical 
areas of the country in order to determine whether or not such legislation would need to be on a federal or 
state level. While we all share the same country, America's landscape as far as reasons for opioid abuse is 
different in each state and even in each region, so those considerations need to be made.  
 
Bioethical Discussion and Future Research on Treatment and Care 
 
Mental health and substance use disorder (SUD) are incredibly important aspects of any discussion related 
to the opioid crisis. It has been shown that mental health disorders are closely associated with problem drug 
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use in the community.15 More than half of the prescription opioids in the US are prescribed to the 16% of 
Americans that suffer from a mental health disorder of some kind.16 These kinds of statistics should tell us 
that addressing mental health in America with regard to the opioid crisis is an extremely important topic. 
Further, the prescribing of opioid medications in patients with mental health disorders must be addressed 
and quelled in order to prevent those who are already at risk of problem drug use from getting their hands 
on the medications they could abuse. 
 
One issue that arises in discussions about the future of treatment and care for addicts across the nation is 
the use of supervised injectable opioid assisted treatment (siOAT) to aid the addict. Utilizing this kind of a 
program allows those struggling with substance use disorder to take their medications in a stable 
environment with the help of a medical professional. Literature has shown that siOAT is effective for 
several outcomes including “retention in treatment, reducing the use of street drugs, and reducing illegal 
activities.”17 This brings with it ethical questions of whether treatment programs like this are enabling the 
user, along with the questions about the long-term efficacy of this and other similar programs. Further 
research must be done in order to establish justification for siOAT. 
 
While addressing incarceration and criminal justice programs is a great place to start when considering the 
opioid crisis, it is important to understand that the issue itself is complex and multi-faceted. There is not 
one solution that can fix the problem. The American Journal of Public Health describes the etiology of 
opioid addiction as addicts using opioids as “a refuge from physical and psychological trauma, concentrated 
disadvantage, isolation, and hopelessness.”18 The article continues by saying that overreliance on opioid 
 
15 Mark Sullivan et al., “Association between mental health disorders, problem drug use, and regular prescription 
opioid use.” Archives of Internal Medicine, 166: 2087-2093.  
16 Matthew Davis, Lewei Lin, Haiyin Liu, and Brian Sites, “Prescription opioid use among adults with mental health 
disorders in the United States.” The Journal of the American Board of Family Medicine. 30, no. 4 (2017): 407-417.  
17 Public Health Ontario, “Effectiveness of supervised injectable opioid agonist treatment (siOAT) for opioid use 
disorder.  
18 Nabarun Dasgupta, “Opioid Crisis: No easy fix to its social and economic determinants,” American Journal of 
Public Health, 108, no. 2 (2018): 182. 
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medications is “emblematic of a health care system that incentivizes quick, simplistic answer to complex 
physical and mental health needs,” and that “simplistic measures to cut access to opioid offer illusory 
solutions to this multidimensional society  
It is clear that the opioid epidemic is one that is fueled not only by improper treatment of addicts, but also 
by a predisposition of a large demographic of the United States to addiction as a result of things such as 
mass trauma, isolation, and learned helplessness. As these factors continue, no amount of criminal justice 
reform will cure the problem. Instead, the approach to the war on drugs needs to be one that comes from 
many angles and addresses many problems at once, rather than trying to use any one plan. 
 
In an article published in the Journal of Pain Research, Schatman describes a discrepancy between opioid 
marketing and observed effects. One particular analgesic, OxyContin, was marketed by Purdue Pharma as 
having a less than 1% chance risk of addiction. While this number seems promising and would advocate 
for the use of OxyContin in many situations, the same study noted that in 2008 alone, the number of non-
medical users of OxyContin increased by almost half a million. This article poses that this deception in the 
marketing of various opioid medications could be a strong contributor to the great growth of the opioid 
crisis in America in recent years.19 The same article looks at the fact that while many options for curbing 
the opioid crisis have been introduced to the public and the medical profession in the past few years, many 
of them show few or no benefits for patients themselves and a lack of actual positive change in the actual 
statistics of the crisis.  
 
One alternative to many of the traditional methods of curbing opioid use that the article discusses is the use 
of tamper-resistant/abuse-deterrent formulations (TR/ADFs) that have the potential to reduce levels of 
overdoses, addiction cases, and deaths. ADFs specifically were extremely effective in decreasing risk for 
 
19 Michal Schatman, “The Health Insurance Industry: Perpetuating the Opioid Crisis through Policies of Cost-
containment and Profitability,” Journal of Pain Research 8, (2015): 153-158. 
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development of abusive tendencies as well as for overdoses, yet the insurance industry has chosen not to 
market for these formulations at all.20 This kind of a focus points to a focus from industry toward 
profitability and cost-containment rather than toward true patient care and risk assessment. What’s worse 
is that in this context, these tactics in the end did not make the insurance companies any more money than 
they might have made before because the overdoses and addiction cases caused by the use of “normal” 
formulary drugs continued to raise hospital stay costs and the costs of other interventions.  
 
While many institutions that deal with addicts and the opioid are required to fight for patient benefit and 
care, it seems that in many ways other institutions only fight for themselves and completely ignore the need 
that is present in potential abusers lives. It has been shown that incarceration alone is not the solution for 
the opioid crisis. Whether utilizing incarceration with better prevention and treatment methods, or 
completely decriminalizing illicit substances and focusing completely on treatment, the truth is that the 
focus must lie solely on the individual struggling with the disease of addiction, not on their action of using. 
As long as that kind of a respect for an individual’s needs are retained, the opioid crisis has a chance to 
improve.  
 
Conclusion 
 
The Bible is clear in many places that we are to remain sober and clear-minded in all areas of life. 1 Peter 
1:13 says that we are to remain alert and fully sober, so that we can be fully focused on Christ and His 
return. While the Bible says that there are no temptations that will push us beyond what we can bear (1 Cor. 
10:13), it’s clear that we need to have a more integrated approach if we are going to fight against the opioid 
crisis. In this same vein, we have to find ways to address the issue before it becomes one. 
  
 
20Ibid.  
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From the literature, it is very clear that America is suffering in many ways because of the opioid epidemic. 
Families are being wrecked, and the jails and prisons are being overcrowded, and the nation still experiences 
yearly increases in the number of addicts and opioid-related overdoses. In this paper we have discussed not 
only some of the origins of the problem in America, but also some of the solutions posited by European 
countries such as Switzerland and Portugal. After examining those acts of legislation, the ramifications of 
implementing such legislation in America was discussed before entering into a bioethical discussion about 
the opioid epidemic and the place for treatment such as supervised injectable opioid assisted treatment. 
While there are various ways to treat or prevent opioid addiction, it is difficult to find a method that works 
in every area of the country for every kind of patient, so careful examination of the options and the ways in 
which those options can be differentiated for use all over the country is important before moving forward 
with any legislation. America obviously has a lot of room to grow, and there are years ahead of fighting for 
sobriety for the people, but the literature shows that if we focus only on incarceration and criminal justice 
rather than treatment of individuals, the epidemic itself will only grow.  
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